Skip to content

A study to compare an Ayurvedic formulation (Simhyadi Choorna Vati) and standard modern medicine in the management of Peenas Vyadhi(Chronic Rhinitis)in School going children.

A randomized comparative clinical trial to evaluate the efficacy of Simhyadi Choorna Vati and Montelukast + Levocetrizine combination in the management of Peenas Vyadhi( Chronic Rhinitis)in school-going children. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103255
Enrollment
35
Registered
2026-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

None listed

Sponsors

PDEAs college of Ayurved And Research centre Nigdi pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children diagnosed with case of Peenas (Chronic Rhinitis) having Nasavrodha(Nasal Congestion) with two or more presenting symptoms like Nasastrava(Rhinorrhea), Kshavathu(Sneezing),Nasakandu (Nasal Itching),Shirashoola(Headache) for atleast 4 weeks.(AAP guidelines) 2. Children between the ages of 6 to 12 years, irrespective of gender, socioeconomic status.

Exclusion criteria

Exclusion criteria: 1. Known case of Acute Sinusitis with fever more than 100oF.. 2. Nasal polyps or any other clinically significant nasal anomaly. 3. Patient having rhinitis but associated with known case of Asthma. 4. Patient who have received surgical procedure in the nasal cavity within 3 months prior to visit. 5. Those who have started immunosuppressive therapy like inhaled corticosteroids.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Simhyadi Choorna Vati and Montelukast + Levocetrizine combination in the management of nasal symptoms such as rhinorrhea, nasal congestion, and nasal itching in school-going children diagnosed with Peenas Vyadhi( Chronic Rhinitis) over 2 weeks.Timepoint: 14 Days study with Follow up on 5th,10th and 14th day

Secondary

MeasureTime frame
To observe the adverse effects of the drug, if any.Timepoint: 14 Days study with Follow up on 5th,10th and 14th day.

Countries

India

Contacts

Public ContactDr Sudha Singh

PDEAs college of Ayurved and Research centre, Nigdi

drsudha2010@gmail.com9975404439

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026